Mesoblast (NASDAQ: MESO) gives director 875,000 incentive options
Rhea-AI Filing Summary
Mesoblast Limited (MESO) reported to U.S. investors that it has issued unquoted options to a director under its employee incentive scheme. On 19 August 2026, key management personnel Philip R. Krause received 875,000 MSBAI options, issued for nil consideration, pursuant to shareholder approval at the 2025 AGM.
Following this grant, Krause holds 3,385,000 options and 28,750 American Depositary Shares. Overall capital now includes 1,298,748,110 ordinary fully paid shares and 89,890,943 MSBAI options on issue, along with several unquoted warrant classes. The options were issued under Listing Rule 7.2 exception 13.
Positive
- None.
Negative
- None.
Key Figures
Options issued to Philip R. Krause: 875,000 options
Director’s options after change: 3,385,000 options
Director’s ADS holdings: 28,750 American Depositary Shares
+5 more
8 metrics
Options issued to Philip R. Krause
875,000 options
MSBAI options issued on 19 August 2026 under employee incentive scheme
Director’s options after change
3,385,000 options
Total options held by Philip R. Krause after the 875,000-option grant
Director’s ADS holdings
28,750 American Depositary Shares
ADS held by Philip R. Krause before and after the reported change
Ordinary shares on issue
1,298,748,110 shares
MSB ordinary fully paid shares quoted on ASX
MSBAI options on issue
89,890,943 options
Unquoted MSBAI options expiring various dates, various exercise prices
MSBAA warrants 2 on issue
2,000,000 warrants
Unquoted MSBAA warrant class outstanding
MSBAO warrants on issue
15,027,327 warrants
Unquoted MSBAO warrant class outstanding
MSBAP ADS warrants on issue
884,838 warrants
Unquoted MSBAP ADS warrant class outstanding
Key Terms
Appendix 3Y, Appendix 3G, employee incentive scheme, Listing Rule 7.2, +2 more
6 terms
Appendix 3Y regulatory
"Appendix 3Y Change of Director’s Interest Notice"
Appendix 3G regulatory
"Appendix 3G - Notification of issue, conversion or payment up of unquoted equity"
employee incentive scheme financial
"+Other securities issued under an +employee incentive scheme that are not intended"
Listing Rule 7.2 regulatory
"Were the +securities issued under an exception in Listing Rule 7.2"
key management personnel financial
"Were any of the +securities issued to +key management personnel (KMP)"
unquoted +securities financial
"issue, conversion or payment up of unquoted +securities"
FAQ
What did Mesoblast Limited (MESO) disclose about new securities in this 6-K?
Mesoblast disclosed the issue of 875,000 unquoted MSBAI options on 19 August 2026 under its employee incentive scheme, granted to director and key management personnel Philip R. Krause, with no cash consideration, pursuant to shareholder approval at the 2025 AGM.
How did Philip Krause’s holdings in MESO change according to this filing?
Philip R. Krause received 875,000 new options, increasing his option holdings from 2,510,000 to 3,385,000 options. His holding of 28,750 American Depositary Shares remains unchanged. The options were granted as part of Mesoblast’s employee incentive scheme.
How many MSBAI options are outstanding for Mesoblast (MESO) after this grant?
After the reported issue, Mesoblast has 89,890,943 MSBAI options on issue. These are unquoted options expiring on various dates and exercisable at various prices, including those granted under the company’s employee incentive scheme.
Were the new MESO options issued under ASX Listing Rule exceptions?
Yes. The 875,000 MSBAI options granted to Philip R. Krause were issued under ASX Listing Rule 7.2 exception 13, meaning the issue fell within an exception and did not require separate security holder approval under Listing Rule 7.1.
AI-generated analysis. How Rhea-AI works. Not financial advice.